Clinical Trials
42 trialsNCT05946668 2026-06-04
Evaluation of Vaginal Microbiome as a Biomarker for the Improvement of Vaginal Health in Women With Breast Cancer, ARISE Study
Ohio State University Comprehensive Cancer Center
Completed
NCT04183218 2026-05-27
Characterizing Chemo-Radiotherapy Treatment-Related Cardiac Changes
Mayo Clinic
Completed
NCT05564650 2026-05-19
Navitoclax in Relapsed or Refractory High-Risk Myelodysplastic Syndrome
Thomas Jefferson University
Phase 1 Completed
NCT05730712 2026-05-15
Pertuzumab, Trastuzumab, Hyaluronidase-zzxf and Enzalutamide for Treatment of Metastatic Castration-Resistant Prostate Cancer
Mayo Clinic
Phase 2 Completed
NCT06635005 2026-05-11
LIN-BRiCK
Ohio State University Comprehensive Cancer Center
Phase NA Completed
NCT06151847 2026-04-30
Lifileucel With Reduced Dose Fludarabine/Cyclophosphamide Lymphodepletion and Interleukin-2 for the Treatment of Patients With Unresectable or Metastatic Melanoma
University of Kansas Medical Center
Phase 2 Completed
NCT03634241 2026-04-16
Pembrolizumab in Preventing Lung Cancer in Patients With Stage I-II Non-Small Cell Lung Cancer or High-Risk Pulmonary Nodules, the IMPRINT-Lung Study
M.D. Anderson Cancer Center
Phase 2 Completed
NCT05107219 2026-04-07
GCC Agonist Signal in the Small Intestine
University of Wisconsin, Madison
Phase 1 Completed
NCT05105100 2026-04-06
Peripheral T Cell Determinants of Response and Resistance to Pembrolizumab in Melanoma
University of California, San Francisco
Completed
NCT06861647 2026-04-01
iSITE
The Wellcome Sanger Institute
Completed
NCT06328621 2026-03-18
Lung Cancer Risk Assessment and Etiology
City of Hope Medical Center
Completed
NCT04312308 2026-02-06
A Study for Identification of Predictive Immune Biomarker for Atezolizumab Therapy in NSCLC Patients
Yonsei University
Completed
NCT05918185 2026-02-03
Evaluation of Comprehensive Geriatric Assessment and Laboratory Biomarkers in Elderly Patients With Multiple Myeloma
Mayo Clinic
Completed
NCT06219434 2025-12-08
Evaluation of a Mindfulness Intervention to Prevent Chemo-brain in Women Preparing for Chemotherapy for Breast Cancer
Thomas Jefferson University
Phase NA Completed
NCT06128525 2025-11-28
Prostate Resection After Microwave Ablation (PRAMA)
University of Southern California
Phase NA Completed
NCT05945290 2025-09-09
Pre-analytical Factors Affecting ctDNA Analysis in Early and Locally Advanced Breast Cancer
Mayo Clinic
Completed
NCT06559709 2025-09-08
A Plant-Based Whole-Foods Meal Delivery Service for Patients With Multiple Myeloma Undergoing Autologous Hematopoietic Cell Transplant
Fred Hutchinson Cancer Center
Phase NA Completed
NCT05047926 2025-08-08
Prehabilitation for Stage IIIC-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients
Mayo Clinic
Phase NA Completed
NCT05764330 2025-08-06
Weight Loss Interventions to Reduce Cancer Progression in Prostate Cancer Patients Under Active Surveillance
Roswell Park Cancer Institute
Phase NA Completed
NCT04581382 2025-07-10
Radiation Therapy, Plasma Exchange, and Immunotherapy (Pembrolizumab or Nivolumab) for the Treatment of Melanoma
Mayo Clinic
Phase EARLY_PHASE1 Completed
NCT06534424 2025-06-27
Clinical Impact of Enhanced Risk Assessments in Women With a BRCA1/2 Mutation, CARE Study
Ohio State University Comprehensive Cancer Center
Phase NA Completed
NCT05524844 2025-05-11
The Microbiome, Bile Acids, and Notch in Barrett's Esophagus (BE)
Columbia University
Completed
NCT03396926 2025-02-28
Pembrolizumab, Capecitabine, and Bevacizumab for Treating Colorectal Cancer
University of California, San Francisco
Phase 2 Completed
NCT05665725 2025-01-31
Siltuximab for the Prevention of CAR T Cell Related Cytokine Release Syndrome in Patients With CD19 Positive Non-Hodgkin Lymphoma
Ohio State University Comprehensive Cancer Center
Phase 1 Completed
NCT05716477 2025-01-09
Blood Test (Guardant Shieldâ„¢) for Screening of Colorectal Cancer in Underserved Patients
Ohio State University Comprehensive Cancer Center
Completed
NCT01937052 2024-12-13
Johns Hopkins Breast Cancer Program Hormone Therapy Longitudinal Database
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Completed
NCT04865133 2024-12-10
Efficacy and Safety of COVID-19 Vaccine in Cancer Patients
Mayo Clinic
Completed
NCT02700230 2024-09-27
Vaccine Therapy in Treating Patients with Malignant Peripheral Nerve Sheath Tumor That is Recurrent or Cannot Be Removed by Surgery
Mayo Clinic
Phase 1 Completed
NCT03071913 2024-09-27
Blood Brain Barrier Differences in Patients with Brain Tumors Undergoing Surgery
Mayo Clinic
Completed
NCT04067960 2024-08-14
Pharmacogenomics Testing in the Optimal Use of Supportive Care Medications in Stage III-IV Cancer
Mayo Clinic
Phase EARLY_PHASE1 Completed
NCT03119883 2024-08-09
Dysregulation of Glutamine Activity in the Pathogenesis of Multiple Myeloma
Mayo Clinic
Phase NA Completed
NCT05112627 2024-08-09
Immunophenotyping in Metastatic Kidney Cancer Patients Receiving Ablative Therapy
Mayo Clinic
Completed
NCT02797600 2024-04-02
Community Awareness, Resources and Education (CARE II) Project: Project 1
Ohio State University Comprehensive Cancer Center
Completed
NCT04169022 2024-02-12
CAR-LAM
Centre Hospitalier Universitaire de Besancon
Phase NA Completed
NCT05740501 2023-08-04
Pharmacokinetic Profiling of Pembrolizumab and Nivolumab in Patients With Melanoma and/or Non-Small Cell Lung Cancer
Mayo Clinic
Completed
NCT02560623 2022-11-17
A Minimally-Invasive Sponge on a String Device for Screening for Barrett's Esophagus
Mayo Clinic
Phase NA Completed
NCT01343121 2021-08-13
Gemtrans
The Christie NHS Foundation Trust
Phase NA Completed
NCT01345513 2020-03-23
Feasibility Clinical Study of Targeted and Genome-Wide Sequencing
University Health Network, Toronto
Completed
NCT02001337 2019-11-07
EXPAND
Mayo Clinic
Completed
NCT03121287 2019-08-26
Early Imaging Biomarkers in NSCLC
University of Michigan Rogel Cancer Center
Completed
NCT02243267 2017-11-08
GI SPORE Colon Biosample Protocol
University of Michigan
Completed
NCT01075425 2016-04-15
Belinostat and Bortezomib in Treating Patients With Relapsed or Refractory Acute Leukemia or Myelodysplastic Syndrome
Virginia Commonwealth University
Phase 1 Completed